ENDO-VIT

Main information

  • Trade name:
  • ENDO-VIT 28 CAP CAP
  • Pharmaceutical form:
  • CAP
  • Composition:
  • 28 CAP
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ENDO-VIT 28 CAP CAP
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

8-6-2017

FDA requests removal of Opana ER for risks related to abuse

FDA requests removal of Opana ER for risks related to abuse

Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is the first time the agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse.

FDA - U.S. Food and Drug Administration

19-3-2018

The LDL Dilemma in Diabetes: How Low Do You Go?

The LDL Dilemma in Diabetes: How Low Do You Go?

Debating the benefits of ultra-low low-density lipoprotein (LDL) cholesterol versus a more reasonable, but still low, level among patients with diabetes, Steve Nissen, MD, of the Cleveland Clinic, Ohio, and Henry N Ginsberg, MD, Irving Professor of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, entertained delegates on March 17 here at ENDO 2018: The Endocrine Society Annual Meeting.

US - RxList

14-2-2018

SUMAVEL DOSEPRO (Sumatriptan) Injection [Endo Pharmaceuticals, Inc.]

SUMAVEL DOSEPRO (Sumatriptan) Injection [Endo Pharmaceuticals, Inc.]

Updated Date: Feb 14, 2018 EST

US - DailyMed

25-1-2018

AVEED (Testosterone Undecanoate) Injection [Endo Pharmaceuticals Solutions Inc.]

AVEED (Testosterone Undecanoate) Injection [Endo Pharmaceuticals Solutions Inc.]

Updated Date: Jan 25, 2018 EST

US - DailyMed

21-12-2017

VOLTAREN (Diclofenac Sodium) Gel [Endo Pharmaceuticals Inc.]

VOLTAREN (Diclofenac Sodium) Gel [Endo Pharmaceuticals Inc.]

Updated Date: Dec 21, 2017 EST

US - DailyMed

15-12-2017

BELBUCA (Buprenorphine Hydrochloride) Film [Endo Pharmaceuticals, Inc.]

BELBUCA (Buprenorphine Hydrochloride) Film [Endo Pharmaceuticals, Inc.]

Updated Date: Dec 15, 2017 EST

US - DailyMed

1-12-2017

LIDODERM (Lidocaine) Patch [Endo Pharmaceuticals, Inc.]

LIDODERM (Lidocaine) Patch [Endo Pharmaceuticals, Inc.]

Updated Date: Dec 1, 2017 EST

US - DailyMed

20-7-2017

VANTAS (Histrelin Acetate) Implant [Endo Pharmaceuticals Solutions Inc.]

VANTAS (Histrelin Acetate) Implant [Endo Pharmaceuticals Solutions Inc.]

Updated Date: Jul 20, 2017 EST

US - DailyMed

6-7-2017

Endo Pharma Agrees to Pull Abuse-Deterrent Opioid

Endo Pharma Agrees to Pull Abuse-Deterrent Opioid

Endo Pharmaceuticals has agreed to remove its abuse-deterrent extended-release formulation of oxymorphone (Opana ER) from the US market, about a month after the US Food and Drug Administration (FDA) asked the company to stop selling the pain medication.

US - RxList

22-6-2017

MEGACE ES (Megesterol Acetate) Suspension [Endo Pharmaceuticals, Inc.]

MEGACE ES (Megesterol Acetate) Suspension [Endo Pharmaceuticals, Inc.]

Updated Date: Jun 22, 2017 EST

US - DailyMed

8-6-2017

FDA Requests Removal of Opana ER for Abuse Risks

FDA Requests Removal of Opana ER for Abuse Risks

Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market.

US - RxList

26-5-2017

SUPPRELIN LA (Histrelin Acetate) Implant [Endo Pharmaceuticals Solutions Inc.]

SUPPRELIN LA (Histrelin Acetate) Implant [Endo Pharmaceuticals Solutions Inc.]

Updated Date: May 26, 2017 EST

US - DailyMed

22-5-2017

VALSTAR (Valrubicin) Solution, Concentrate [Endo Pharmaceuticals Solutions Inc.]

VALSTAR (Valrubicin) Solution, Concentrate [Endo Pharmaceuticals Solutions Inc.]

Updated Date: May 22, 2017 EST

US - DailyMed